Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

La diversidad genética de los tumores con deficiencia de reparación de desajuste influye en la respuesta a la inmunoterapia anti-PD-1

  • 0Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, MD 21287, USA.
Clinical Neuroscience (new York, N.y.) +

|

|

Resumen

Este resumen es generado por máquina.

Los tumores con deficiencia de reparación por desajuste (MMR-d) muestran respuestas variables a los inhibidores de la PD-1. La inestabilidad de los microsatélites y la carga mutacional de inserción-eliminación tienen un impacto significativo en la eficacia del tratamiento en estos cánceres.

Área De La Ciencia

  • En el campo de la oncología
  • Inmunología
  • La genética

Sus Antecedentes

  • La deficiencia de reparación de desajuste (MMR-d) conduce a una alta carga mutacional tumoral, mejorando la inmunogenicidad.
  • A pesar de esto, los pacientes con tumores MMR-d presentan respuestas variables a los inhibidores del punto de control inmunológico PD-1, y muchos permanecen refractarios.

Objetivo Del Estudio

  • Investigar la relación entre los niveles de inestabilidad de los microsatélites (MSI) y la respuesta a la inmunoterapia de bloqueo PD-1 en los tumores MMR-d.
  • Identificar las características mutacionales específicas asociadas con resultados de tratamiento variables.

Principales Métodos

  • Análisis de datos experimentales y clínicos de modelos de tumores en humanos y ratones sometidos a RMM.
  • Evaluación de la intensidad de inestabilidad del microsatélite (MSI) y de la carga mutacional, incluidas las mutaciones de inserción-eliminación (indel).

Principales Resultados

  • El grado de inestabilidad del microsatélite (MSI) y la carga mutacional general se correlacionan con la variabilidad de la respuesta al bloqueo PD-1.
  • La acumulación de mutaciones de inserción-deleción (indel) es un factor clave asociado con el grado de respuesta.

Conclusiones

  • La intensidad de inestabilidad de los microsatélites y la carga mutacional son determinantes críticos de la respuesta a la inmunoterapia anti-PD-1 en los cánceres MMR-d.
  • La caracterización de todo el genoma de MSI y la carga mutacional puede mejorar el perfil del paciente para la terapia de bloqueo de PD-1.

Videos de Conceptos Relacionados

Mismatch Repair 01:36

43.6K

Overview

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.

The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair

The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount...

Mismatch Repair 01:20

6.4K

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Tumor Immunotherapy 01:27

1.8K

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Overview of DNA Repair 02:25

33.5K

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...

Diversity in Cell Signaling Responses 01:22

7.7K

The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response 01:15

360

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...